Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations
Drug Topics
JULY 2, 2025
Drug Topics: What will be the likely impacts of this change that pharmacists will need to communicate with their patients?
2025 Communication Compounding 
Gaps Remain in MOUD Access Across Opioid Treatment Programs
Drug Topics
JUNE 30, 2025
March 18, 2025. Accessed June 30, 2025. Importance of Communication in Buprenorphine Initiation | APhA 2025. March 25, 2025. Accessed June 30, 2025. Drug Topics. Nowosielski B. Drug Topics. What Does the Future of Pain Medicine Look Like?
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information
Drug Topics
JULY 6, 2025
Further, she underscored the need for continued patient education, transparent communication, and a commitment to evidence-based medical guidance in an increasingly complex health care environment. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Pharmacy Leaders Enhance Culture with Continuous Learning | McKesson ideaShare
Drug Topics
JULY 26, 2025
In the world of pharmacy management, success hinges on more than just dispensing medications—it's about creating a culture of communication, continuous learning, and emotional intelligence.
Q&A: Pharmacists Play Essential Role in Insulin Therapy Success
Drug Topics
JULY 15, 2025
Pharmacists play a vital role in helping patients understand and manage insulin therapy through clear communication, relatable analogies, and personalized education tailored to individual regimens and lifestyles.
Independent Pharmacists’ Unique Role During Disaster Management Efforts
Drug Topics
JUNE 11, 2025
One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires. Aside from properly preparing medications during a disaster, Phillips mentioned the importance of establishing communication with patients. I think text-messaging services have drastically improved,” Phillips said.
ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust
Drug Topics
JUNE 20, 2025
They stress that rebuilding trust is challenging and requires careful, empathetic communication. Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations.
FDA Approves Widaplik for Treatment of Hypertension
Drug Topics
JUNE 9, 2025
June 9, 2025. Accessed June 9, 2025. Recent Videos Related Content Statins Have No Additional Antidepressive Effects as Add-On Treatment Ashley Gallagher June 5th 2025 Article Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.
Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
Drug Topics
JUNE 18, 2025
Community pharmacies, which are very accessible to the public, are well positioned to address social determinants of health (SDOH), including food insecurity. In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. June 18, 2025.
How AI and machine learning are transforming drug discovery
Pharmaceutical Technology
JUNE 26, 2025
Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals.
Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025
Drug Topics
JUNE 23, 2025
Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.
Late-Life Mood Disorders Could Be Associated With Alzheimer Disease, Dementias
Drug Topics
JUNE 11, 2025
June 9, 2025. Accessed June 10, 2025. Kreckel, RPh June 10th 2025 Article Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs. REFERENCES 1. Mood disorders in late life may be early warning signs for dementia. News release. Alzheimers Dement. doi:10.1002/alz.70195
FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe
Drug Topics
JULY 18, 2025
July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. News Release. October 23, 2017. News Release.
The future of clinical pharmacy in Europe with ESCP president Monika Lutters
Hospital Pharmacy Europe
MARCH 18, 2025
Its also challenging to convince hospital directors to invest in clinical pharmacy when financial pressures compound the issue, Dr Lutters notes. Worryingly, the advent of better information and communications technologies solutions in recent years is not helping matters. This is a huge problem.
Progress in Dermatology Paves the Way for Vaccine Development
Drug Topics
JUNE 20, 2025
2025 Jan 26;13(2):125. Accessed June 20, 2025. Accessed June 20, 2025. Accessed June 20, 2025. Accessed June 20, 2025. Vaccines (Basel). doi: 10.3390/vaccines13020125. Recommended vaccinations for adults. November 22, 2024. Chickenpox (varicella) vaccine safety. July 31, 2024. Jefferson Health. September 13, 2024.
MetrioPharm gains orphan drug status from EMA for MP1032
Pharmaceutical Technology
JULY 30, 2025
July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. MetrioPharm’s lead compound, MP1032, has received orphan drug designation (ODD) from the European Medicines Agency (EMA) for treating Duchenne muscular dystrophy (DMD) in children.
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharmaceutical Technology
JUNE 6, 2025
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
Q&A: How ACIP Changes Could Reshape Patient Care
Drug Topics
JULY 5, 2025
He emphasizes the critical need for health care providers, especially pharmacists, to independently evaluate scientific evidence, maintain open communication with patients, and proactively address vaccine-related concerns. Is this really, truly evidence-based, or is this ideology-driven recommendations?
Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF
Pharmacy Times
JULY 24, 2025
The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025. Treatment is more of an art,” she added, describing HFpEF as a condition that often requires tinkering and frequent communication with the patient to get the treatments right. March 17, 2025. Accessed June 27, 2025. News release. Subscribe Now!
Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs
Pharmacy Times
JUNE 13, 2025
CPAs are essentially signed contracts that have formal agreements with well-defined scopes, which allow for collaboration and communication among health care professionals in areas lacking aspects of health care, according to Klepser. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention.
HS market forecast to reach $7.8bn across 7MM by 2034
Pharmaceutical Technology
JULY 28, 2025
GlobalData Healthcare July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Vitalii Vodolazskyi / Shutterstock.com. compound annual growth rate (CAGR) is largely attributed to the launch of novel biologics and small molecules targeting multiple inflammatory pathways beyond TNF-alpha inhibition.
Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance
Pharmacy Times
JULY 28, 2025
Accessed May 29, 2025. Communicating with vaccine-hesitant parents: a narrative review. Accessed May 29, 2025. Grillo, MBA, RPh Key Takeaways Vaccination has saved millions of lives, yet vaccine hesitancy remains a significant global health threat, fueled by misinformation and systemic barriers. September 20, 2024. Acad Pediatr.
The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications
Pharmacy Times
JUNE 17, 2025
SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider.
Evaluation of a Pharmacy-Delivered Oncofertility Intervention
Pharmacy Times
JUNE 11, 2025
Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.
Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy
Pharmacy Times
JUNE 20, 2025
They have a team of highly skilled distribution professionals who can juggle efficacy and safety checks along with compounding as if they were conductors of a world-class symphony. These job duties each require different skill sets, from writing and verbal communication to process development, technical aptitude, and deep clinical expertise.
FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency
Pharmacy Times
JULY 7, 2025
We are communicating this information now to allow time for patients to work closely with their health care teams to develop alternative treatment plans.” Released June 30, 2025. Accessed July 7, 2025. Accessed July 7, 2025. Published February 21, 2025. Accessed July 7, 2025. News Release. Rupa Health.
Corticophobia Can Significantly Impact AD Management Strategies
Drug Topics
JULY 8, 2025
Accessed July 8, 2025. Recent Videos Related Content Progress in Dermatology Paves the Way for Vaccine Development Brian Nowosielski June 20th 2025 Article Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary. Aust Prescr. 2023 Jun;46(1):9-12.
Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC
Pharmacy Times
JULY 9, 2025
High doses of steroids, whether administered before or during treatment with an immune checkpoint inhibitor (ICI), caused the tumors of patients with non-small cell lung cancer (NSCLC) to shrink less than those not on steroids, according to recent study results published by investigators in Cancer Research Communications. July 7, 2025.
Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
Pharmacy Times
JUNE 8, 2025
At the American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2025 meeting, presenter Madison Wood, PharmD, CPh, BCPS, reviewed a groundbreaking model for integrating specialty pharmacists directly into neurology care teams.
J&J seeks FDA approval for icotrokinra to treat psoriasis
Pharmaceutical Technology
JULY 22, 2025
July 22, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook PsO is an immune-mediated disease characterised by rapid skin cell proliferation leading to inflamed plaques that can cause discomfort or pain. Give your business an edge with our leading industry insights. Login Registration is disabled.
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
Pharmacy Times
JULY 10, 2025
Medication Adherence Requires Personalized Communication Alva emphasized that effective counseling about medications—especially those with intimidating FDA warnings—requires compassionate, patient-centered communication.
PillPack from Amazon Pharmacy Expands to Medicare Part D: How PillPack and 24/7 Support Are Transforming Medication Access and Adherence
Pharmacy Times
JULY 15, 2025
Lastly, just to touch on health literacy—when you add in our simplified digital communication and educational touch points, you really create space for health literacy as well. Q: As PillPack from Amazon Pharmacy expands its reach into the Medicare Part D market, how do you see the role of the pharmacy evolving within this model?
To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential
Pharmacy Times
JUNE 5, 2025
To properly and responsibly allocate these medications to patients, pharmacists and health professionals must develop proper literacy and adeptness at using new products such as Detect-A-Dose while maintaining adequate communication and multidisciplinary teamwork. Accessed Online via StatPearls on June 5, 2025. Released May 20, 2025.
Meeting Preview: NPhA, SNPhA Annual Convention
Drug Topics
JULY 18, 2025
This year’s National Pharmaceutical Association (NPhA) and Student National Pharmaceutical Association (SNPhA) Annual Convention, taking place August 1 to 4 in Cincinnati, Ohio, offers a powerful blend of professional development, community connection, and health equity advocacy.
FDA Posts Slate of Seven Warning Letters Following Company Inspections
PharmTech
JUNE 12, 2025
Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. –
Senator Durbin Has Questions About FDA’s “Operational Capacity” to Oversee DTC Prescription Drug Advertising Amid Workforce Reductions – Don’t We All?
The FDA Law Blog
JUNE 1, 2025
Compounding these concerns is the fact that four of the top officials in OPDP, including the director and deputy director, have left the agency, and regulatory counsel and policy staff involved in OPDP research were laid off as part of the RIF orders.
Significant Knowledge Gap Exists in Patient Awareness of Psoriatic Disease
Drug Topics
JUNE 11, 2025
1 “Our results also show a potential for enhancing communication between patients and [providers] to align treatment goals better and empower shared decision-making.” Accessed June 11, 2025. Accessed June 11, 2025. Accessed June 11, 2025. National Institute of Arthritis and Musculoskeletal and Skin Diseases. October 2023.
OTC Case Studies: Summer Skin Care
Pharmacy Times
JUNE 20, 2025
She is deeply passionate about embracing the pillars of lifestyle medicine, self-care, effective communication, and inclusivity to create lasting positive health and wellness outcomes. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025.
From Trial to Practice in the Evolving Landscape of Hematologic Malignancies
Pharmacy Times
JUNE 18, 2025
Then we talk through the clinical data together with our providers so they fully understand both the limitations of the study and the benefits and what they can expect and communicate to their patients. Pharmacy Time s : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Mok : I love OPC.
Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs
Pharmaceutical Technology
JUNE 12, 2025
Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.
Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
Pharmaceutical Technology
JUNE 24, 2025
Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug.
The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet
Pharmaceutical Commerce
JULY 16, 2025
1 In response to this immense demand, coupled with high costs and accessibility issues, compounded alternatives have emerged as a seemingly pragmatic solution. However, these compounded GLP-1s are creating a significant, often underestimated, legal, reputational, and financial minefield for startups and the broader life sciences industry.
Draig secures $140m for neuropsychiatric disorder therapies
Pharmaceutical Technology
JUNE 19, 2025
June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Draig Therapeutics founders: L-R: John Atack, Ruth McKernan and Simon Ward. These compounds have the potential for addressing a spectrum of neuropsychiatric disorders that currently lack adequate treatment options. Credit: Draig Therapeutics/ GlobeNewswire.
Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation
Pharmacy Times
JULY 3, 2025
Pharmacy Times : How does the team ensure smooth transitions from inpatient to outpatient transplant care, particularly regarding medication management?
Let's personalize your content